Artificial Intelligence has helped researchers make major progress in treating an incurable childhood brain cancer. 

Pioneered at The Royal Marsden NHS Foundation Trust, with support from the NIHR BRC at The Royal Marsden and ICR, liquid biopsies allow clinicians at The Royal Marsden to personalise treatments for a range of cancers and spot recurring disease sooner using a simple blood test. 

Dr Hardeep Singh Kalsi is a Clinical Research Fellow, whose role is funded by The Royal Marsden Cancer Charity, and member of the NIHR BRC’s Early Diagnosis & Detection team.

Friday 4 February marks World Cancer Day, aimed at raising awareness of cancer and its prevention, diagnosis and treatment.

As Head of Clinical Genomics (Research) at The Royal Marsden, Professor Michael Hubank leads the Clinical Genomics Translational Research Team in the Centre for Molecular Pathology – a state-of-the-art facility that is funded through the NIHR BRC.

By using sophisticated computing tools and artificial intelligence to uncover crucial clues about tumours, the new Integrated Pathology Unit at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, is set to bring the discipline into the 21st century.

A study trialling a pioneering digital self-help tool to aid men experiencing negative side effects of prostate cancer treatment opened this week at The Royal Marsden NHS Foundation Trust.

It has been one year since we launched Cancer Patients Voice, our online platform that gives patients, carers and members of the public the opportunity to get involved in cancer research and care. 

A grateful 74-year-old martial artist has praised south London researchers for giving him his life back.

The NIHR Biomedical Research Centre at The Royal Marsden and The Institute of Cancer Research, London, in line with its strategy for facilitating effective patient and public involvement and engagement (PPIE), has put out a call for PPI/E research proposals.